BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22427184)

  • 1. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Lim JS; Kim D; Baek SE; Myoung S; Choi J; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW; Keum KC
    Eur Radiol; 2012 Aug; 22(8):1693-700. PubMed ID: 22427184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
    Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
    Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Kim SH; Lee JM; Gupta SN; Han JK; Choi BI
    J Magn Reson Imaging; 2014 Sep; 40(3):730-7. PubMed ID: 24307571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
    Zou HH; Yu J; Wei Y; Wu JF; Xu Q
    J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
    Seierstad T; Hole KH; Grøholt KK; Dueland S; Ree AH; Flatmark K; Redalen KR
    Br J Radiol; 2015 Jul; 88(1051):20150097. PubMed ID: 25899892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer.
    Pham TT; Liney G; Wong K; Rai R; Lee M; Moses D; Henderson C; Lin M; Shin JS; Barton MB
    BMC Cancer; 2017 Jul; 17(1):465. PubMed ID: 28676107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
    Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Contrast-enhanced Magnetic Resonance Imaging Evaluation of Whole Tumour Perfusion Heterogeneity Predicts Distant Disease-free Survival in Locally Advanced Rectal Cancer.
    Pham TT; Wong K; Liney G; Lim S; Graham PL; Borok N; Truong MX; Rai R; Henderson C; Lee M; Barton MB
    Clin Oncol (R Coll Radiol); 2022 Sep; 34(9):561-570. PubMed ID: 35738953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
    J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor re: Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Gollub MJ; Gultekin DH; Schwartz LH
    Eur Radiol; 2013 May; 23(5):1297-8. PubMed ID: 23179526
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of diffusion-weighted magnetic resonance imaging in prediction of the response to preoperative chemoradiotherapy in rectal carcinoma].
    Liang X; Zhang HM; Ye F; Ouyang H; Zhao XM; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):133-7. PubMed ID: 26899334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim YC; Lim JS; Keum KC; Kim KA; Myoung S; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW
    J Magn Reson Imaging; 2011 Sep; 34(3):570-6. PubMed ID: 21751285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
    Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma.
    Kassam Z; Burgers K; Walsh JC; Lee TY; Leong HS; Fisher B
    Abdom Radiol (NY); 2019 Nov; 44(11):3641-3651. PubMed ID: 31327041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancer.
    Pham TT; Liney G; Wong K; Henderson C; Rai R; Graham PL; Borok N; Truong MX; Lee M; Shin JS; Hudson M; Barton MB
    Phys Imaging Radiat Oncol; 2021 Apr; 18():26-33. PubMed ID: 34258404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
    Yeo SG; Kim DY; Kim TH; Jung KH; Hong YS; Chang HJ; Park JW; Lim SB; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):164-71. PubMed ID: 20004532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.